Natalie Liu

Natalie Liu

Auto-generated profile, based on publicly available information

Natalie Liu

Department of Surgery, University of Wisconsin, Madison, Wisconsin

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
NLNatalie Liu
Natalie Liu
JBJen Birstler
Jen Birstler
MVManasa Venkatesh
Manasa Venkatesh
LHLawrence Hanrahan
Lawrence Hanrahan
GCGuanhua Chen
Guanhua Chen
LFLuke M. Funk
Luke M. Funk
Background: Studies have found associations between increasing BMIs and the development of various chronic health conditions. The BMI cut points, or thresholds beyond which comorbidity incidence can be accurately detected, are unknown. Objective: The aim of this study is to identify whether BMI cut points exist for 11 obesity-related comorbidities. Methods: US adults aged 18-75 years who had ≥3 health care visits at an academic medical center from 2008 to 2016 were identified from eHealth records. Pregnant patients, patients with cancer, and patients who had undergone bariatric surgery were excluded. Quantile regression, with BMI as the outcome, was used to evaluate the associations between BMI and disease incidence. A comorbidity was determined to have a cut point if the area under the receiver operating curve was >0.6. The cut point was defined as the BMI value that maximized the Youden index. Results: We included 243,332 patients in the study cohort. The mean age and BMI were 46.8 (SD 15.3) years and 29.1 kg/m2, respectively. We found statistically significant associations between increasing BMIs and the incidence of all comorbidities except anxiety and cerebrovascular disease. Cut points were identified for hyperlipidemia (27.1 kg/m2), coronary artery disease (27.7 kg/m2), hypertension (28.4 kg/m2), osteoarthritis (28.7 kg/m2), obstructive sleep apnea (30.1 kg/m2), and type 2 diabetes (30.9 kg/m2). Conclusions: The BMI cut points that accurately predicted the risks of developing 6 obesity-related comorbidities occurred when patients were overweight or barely met the criteria for class 1 obesity. Further studies using national, longitudinal data are needed to determine whether screening guidelines for appropriate comorbidities may need to be revised.

1 October 2019 in Journal of Surgical Research
Verified
Journal Article
Closed access
NLNatalie Liu
Natalie Liu
MCMeghan C. Cusack
Meghan C. Cusack
MVManasa Venkatesh
Manasa Venkatesh
APAnisa L. Pontes
Anisa L. Pontes
GSGrace Shea
Grace Shea
LFLuke M. Funk
Luke M. Funk

22 August 2022 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Closed access
JMJacqueline A. Murtha
Jacqueline A. Murtha
MVManasa Venkatesh
Manasa Venkatesh
NLNatalie Liu
Natalie Liu
DJDawda Jawara
Dawda Jawara
BHBret M. Hanlon
Bret M. Hanlon
LFLuke M. Funk
Luke M. Funk


11 December 2025 in Surgery
Verified
Journal Article
Closed access
NLNatalie Liu
Natalie Liu
SASullivan A. Ayuso
Sullivan A. Ayuso
HHHerbert M. Hedberg
Herbert M. Hedberg
KKKristine M. Kuchta
Kristine M. Kuchta
EDErvin W. Denham
Ervin W. Denham
MUMichael B. Ujiki
Michael B. Ujiki

31 August 2020 in JMIR Preprints
Verified
Preprint
Open access
NLNatalie Liu
Natalie Liu
JBJen Birstler
Jen Birstler
MVManasa Venkatesh
Manasa Venkatesh
LHLawrence Hanrahan
Lawrence Hanrahan
GCGuanhua Chen
Guanhua Chen
LFLuke M. Funk
Luke M. Funk
BACKGROUND Studies have found associations between increasing BMIs and the development of various chronic health conditions. The BMI cut points, or thresholds beyond which comorbidity incidence can be accurately detected, are unknown. OBJECTIVE The aim of this study is to identify whether BMI cut points exist for 11 obesity-related comorbidities. METHODS US adults aged 18-75 years who had ≥3 health care visits at an academic medical center from 2008 to 2016 were identified from eHealth records. Pregnant patients, patients with cancer, and patients who had undergone bariatric surgery were excluded. Quantile regression, with BMI as the outcome, was used to evaluate the associations between BMI and disease incidence. A comorbidity was determined to have a cut point if the area under the receiver operating curve was >0.6. The cut point was defined as the BMI value that maximized the Youden index. RESULTS We included 243,332 patients in the study cohort. The mean age and BMI were 46.8 (SD 15.3) years and 29.1 kg/m2, respectively. We found statistically significant associations between increasing BMIs and the incidence of all comorbidities except anxiety and cerebrovascular disease. Cut points were identified for hyperlipidemia (27.1 kg/m2), coronary artery disease (27.7 kg/m2), hypertension (28.4 kg/m2), osteoarthritis (28.7 kg/m2), obstructive sleep apnea (30.1 kg/m2), and type 2 diabetes (30.9 kg/m2). CONCLUSIONS The BMI cut points that accurately predicted the risks of developing 6 obesity-related comorbidities occurred when patients were overweight or barely met the criteria for class 1 obesity. Further studies using national, longitudinal data are needed to determine whether screening guidelines for appropriate comorbidities may need to be revised.